These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15492238)

  • 1. COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas.
    Dornan D; Bheddah S; Newton K; Ince W; Frantz GD; Dowd P; Koeppen H; Dixit VM; French DM
    Cancer Res; 2004 Oct; 64(20):7226-30. PubMed ID: 15492238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
    Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
    Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
    Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin ligase COP1 is a critical negative regulator of p53.
    Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
    Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage.
    Dornan D; Shimizu H; Mah A; Dudhela T; Eby M; O'rourke K; Seshagiri S; Dixit VM
    Science; 2006 Aug; 313(5790):1122-6. PubMed ID: 16931761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.
    Su CH; Zhao R; Zhang F; Qu C; Chen B; Feng YH; Phan L; Chen J; Wang H; Wang H; Yeung SC; Lee MH
    Cancer Res; 2011 Feb; 71(3):884-94. PubMed ID: 21135113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
    Lin J; Tang H; Jin X; Jia G; Hsieh JT
    Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
    Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
    J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of constitutive photomorphogenic 1 (COP1) and p27 tumor suppressor protein expression in ovarian cancer.
    Ko EJ; Oh YL; Kim HY; Eo WK; Kim H; Kim KH; Koh SB; Ock MS; Choi YH; Kim A; Choi HH; Park EJ; Cha HJ
    Genes Genomics; 2019 Aug; 41(8):879-884. PubMed ID: 31028655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.
    Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H
    Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
    Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
    Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging and kinetics of the bimolecular complex formed by the tumor suppressor p53 with ubiquitin ligase COP1 as studied by atomic force microscopy and surface plasmon resonance.
    Moscetti I; Bizzarri AR; Cannistraro S
    Int J Nanomedicine; 2018; 13():251-259. PubMed ID: 29379285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes.
    Cuadros M; Cano C; López FJ; López-Castro R; Concha A
    Pathobiology; 2013; 80(1):32-40. PubMed ID: 22832278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.
    Karamurzin Y; Leitao MM; Soslow RA
    Am J Surg Pathol; 2013 Mar; 37(3):356-67. PubMed ID: 23282975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
    Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
    Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.
    Shao J; Teng Y; Padia R; Hong S; Noh H; Xie X; Mumm JS; Dong Z; Ding HF; Cowell J; Kim J; Han J; Huang S
    Neoplasia; 2013 Sep; 15(9):1075-85. PubMed ID: 24027432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
    Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
    Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu.
    Hakim AA; Barry CP; Barnes HJ; Anderson KE; Petitte J; Whitaker R; Lancaster JM; Wenham RM; Carver DK; Turbov J; Berchuck A; Kopelovich L; Rodriguez GC
    Cancer Prev Res (Phila); 2009 Feb; 2(2):114-21. PubMed ID: 19174584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M; Sun Y
    Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.